FOXP3 and cervical carcinoma: Intriguingly, although more and more data had provided first evidence for FoxP3 expression localized also in cancer cells, our preliminary trial has showed that the positive expression of FoxP3 was only observed in the nucleus of regulatory T cells rather than in cervical carcinoma cell lines or cervical cancer cells by immunohistochemical staining.